Stay updated with breaking news from Gland Dysfunction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study met its primary endpoint and showed significant and clinically meaningful improvements in multiple symptoms of Contact Lens Discomfort and signs of concomitant Meibomian Gland Dysfunction
/PRNewswire/ -- The "Meibomian Gland Dysfunction - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering. This report...
MIEBO is the First and Only Prescription Eye Drop Approved for Dry Eye Disease that Directly Targets Tear Evaporation, Based on Consistent Results from Two Consecutive Pivotal Phase 3 Trials Bausch
-- Robust safety and efficacy data supports advancing AZR-MD-001 into Phase 3 clinical trials --TEL AVIV, Israel--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced multiple pre...
TEL AVIV, Israel & MELBOURNE, Australia--(BUSINESS WIRE)--Azura Ophthalmics Ltd., a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced that positive 3-month efficacy and safety results from its Phase 2b study of AZR-MD-0...